Related Experiment Video

Updated: Mar 18, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

7.0K

Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression

Yujie Duan1, Ling Tian1, Qingzhu Gao1

  • 1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, PR China.

Oncotarget
|June 29, 2016
PubMed

Insights

AT-rich interactive domain 2 (ARID2) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Downregulation of ARID2 promotes HCC cell proliferation by increasing cell cycle progression, highlighting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Somatic mutations in SWI/SNF chromatin remodeling complexes are implicated in hepatocellular carcinoma (HCC) development.
  • The specific role of AT-rich interactive domain 2 (ARID2) in HCC pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms of AT-rich interactive domain 2 (ARID2) in hepatocellular carcinoma (HCC).
  • To determine the impact of ARID2 expression levels on HCC cell proliferation and tumor growth.

Main Methods:

  • Quantitative analysis of ARID2 expression in HCC tissues versus non-tumorous tissues.
  • In vitro studies involving restoration and knockdown of ARID2 in hepatoma cells.
  • In vivo tumor growth assays in mice.
  • Cell cycle analysis and Western blotting to assess protein expression and phosphorylation.

Main Results:

  • ARID2 expression is significantly downregulated in HCC tissues.
  • Restoration of ARID2 suppresses hepatoma cell proliferation and tumor growth, while ARID2 knockdown enhances them.
  • ARID2 suppression accelerates G1/S cell cycle transition via upregulation of cyclin D1, cyclin E1, CDK4, and Rb phosphorylation.
  • ARID2 interacts with E2F1, reducing E2F1/RNA Pol II binding to CCND1 and CCNE1 promoters.

Conclusions:

  • ARID2 functions as a tumor suppressor in HCC by inhibiting cell cycle progression.
  • ARID2 represses cyclin D1 and cyclin E1 expression, thereby controlling hepatoma cell proliferation.
  • ARID2 represents a potential therapeutic target for HCC treatment.
Keywords:
ARID2SWI/SNF complexcell-cycle arresthepatocellular carcinomathe Rb/E2F pathway

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K